EPINEPHRINE
- Product NDC
- 62250-102
- Requested package NDC
- 62250-102-01
- 11-digit product format
- 622500102
- Labeler code
- 62250
- Product ID
- 62250-102_3cfb1126-cf17-4f86-8568-653b3050e1b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- EPINEPHRINE
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Belcher Pharmaceuticals, LLC
- Application
- NDA205029
- Marketing category
- NDA
- Marketing start
- 2022-02-28
- Marketing end
- 0000-00-00
- Substance
- EPINEPHRINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 62250-102 | 62250-102-01 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205029-001 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 |
| N205029-002 | EPINEPHRINE | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 |
| N205029-003 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | |
| N205029-004 | EPINEPHRINE | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 |
| N205029-005 | EPINEPHRINE | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-03-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N205029-001 | AP |
| N205029-002 | AP |
| N205029-004 | AP |
| N205029-005 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-03-04 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2024-02-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | AP | RLD, RS | 2022-02-04 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2022-02-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | AP | RLD, RS | 2014-07-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-002 | EPINEPHRINE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2022-02-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-003 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2023-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-004 | EPINEPHRINE | 30MG/30ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-02-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-005 | EPINEPHRINE | 1MG/ML (1MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | RLD, RS | 2024-03-04 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N205029-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N205029-005 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N205029-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205029-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | AP | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-004 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N205029-005 | AP | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 10004700 | 2034-08-14 | U-2325 | Drug product, Delist requested | 2018-06-29 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 10039728 | 2034-08-14 | U-1828 | Delist requested | 2018-08-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1829 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1828 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N205029-001 | 9283197 | 2034-08-15 | U-1830 | Drug product, Delist requested | 2016-04-07 | d06236e962d9… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0b4ec9ca-d305-43fc-88dd-7a510313efe0 | Product name | 1 | 20260105 |
| bb209f42-a85f-4fee-9d3d-c9dded168625 | Product name | 1 | 20251208 |
| 49628fc7-2031-4c28-bd31-0ef3aa8f44a3 | Product name | 3 | 20251118 |
| cbf85893-59ef-423f-87d4-a573c000a8b9 | Product name | 8 | 20250731 |
| b5b1095b-40cd-8a9e-b111-502545045b07 | Product name | 4 | 20250325 |
| e190029e-423b-473c-8e04-2ada59b5b711 | Product name | 1 | 20250314 |
| e0031c74-3853-42bc-8e10-86dbbe83992e | Product name | 2 | 20231116 |
| f7046b89-2016-499a-adc6-78479172abc6 | Product name | 1 | 20230425 |
| 2686d634-e712-4007-8dbf-3d37c6c4d71f | Product name | 1 | 20181121 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| bd49bb86-2d32-4a7a-a594-eeda2e29af42 | Product name | 1 | 20180118 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 3becbe78-12d9-4ad2-9b4c-1e36f8d1303a | Product name | 1 | 20170815 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62250-102-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-43fc-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use EPINEPHRINE INJECTION USP safely and effectively. See full prescribing information for EPINEPHRINE INJECTION USP. EPINEPHRINE INJECTION, USP 10 mg/10 mL (1 mg/mL) Multiple Dose Vial, for intravenous, intramuscular, subcutaneous use Initial U.S. Approval: 1939 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62250-102-01 | EPINEPHRINE | 1 in 1 CARTON | INJECTION | 1 | 1 | |
| 62250-102-01 | EPINEPHRINE | 10 mL in 1 VIAL | INJECTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5726eeca-db88-ba8e-e063-6294a90a927d | 2026-08-03 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 386519ba-7a44-4edd-9eb1-748419b7a71b | 2026-07-06 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | Henry Schein, Inc. | af10f2bb-b0ad-45a6-b525-e715613350af | 2026-01-13 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 7499cbca-b8fe-4fc3-a318-13859ab989a7 | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | 3fd8dd51-0aeb-43dd-9de0-c11b0330b15e | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | BPI Labs, LLC | db18519b-82a9-435b-85c7-a040d644f057 | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | BPI Labs, LLC | 5b5282a9-b149-4f0a-978e-5adbf48ec8aa | 2025-12-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | ProPharma Distribution | 384445ac-0696-e367-e063-6394a90a019f | 2025-12-18 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | Medical Purchasing Solutions, LLC. | 409581e7-ab70-41f3-e063-6294a90a15dc | 2025-10-07 | Warnings, Adverse reactions | 205029 NDA205029 |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 5ba14408-c8fb-4734-aad9-ee19696acac2 | 2025-09-26 | Warnings, Adverse reactions | 205029 NDA205029 |
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 677c33a2-4e16-406e-e053-2991aa0a4594 | 2022-10-13 | Warnings, Adverse reactions | 205029 NDA205029 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310132 | EPINEPHrine 1 MG/ML (1:1000) Injectable Solution | PSN | 6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1 | 1 |
| 310132 | epinephrine 1 MG/ML Injectable Solution | SCD | 6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1 | 1 |
| 310132 | epinephrine (as epinephrine hydrochloride) 1 MG/ML Injectable Solution | SY | 6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1 | 1 |
| 310132 | epinephrine 1:1000 Injectable Solution | SY | 6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1 | 1 |
| 310132 | epinephrine 500 MCG per 0.5 ML Injectable Solution | SY | 6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62250-102-01 | 62250010201 | 1 VIAL in 1 CARTON (62250-102-01) > 10 mL in 1 VIAL | 1 vial | 2022-02-28 | 0000-00-00 | No | No | Current |